Type 2 Diabetes Clinical Trials in Cincinnati, Ohio

3 studies are recruiting for type 2 diabetes in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

    CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in th…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati, Ohio
    Locations
    61 in total
    Run by
    Sparrow Pharmaceuticals

    See if you can join NCT07296484 on ClinicalTrials.gov

  2. AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

    This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diabetes who are at higher risk of heart and blood vessel problems and are already taking 1 to 3 diabetes medications. There are 2 study treatments in thi…

    Stage
    Phase 3
    Ages
    45 and older
    Site
    Univ of Cincinnati Med Cent, Cincinnati, Ohio
    Locations
    330 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07797335 on ClinicalTrials.gov

  3. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Childrens Hospital Medical Center, Cincinnati, Ohio
    Locations
    51 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06739122 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.